Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 4
2013 3
2014 2
2015 10
2016 7
2017 8
2018 8
2019 4
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer.
Ferraro DA, Muehlematter UJ, Garcia Schüler HI, Rupp NJ, Huellner M, Messerli M, Rüschoff JH, Ter Voert EEGW, Hermanns T, Burger IA. Ferraro DA, et al. Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):147-159. doi: 10.1007/s00259-019-04511-4. Epub 2019 Sep 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31522272
68Ga-PSMA-11 PET/MR Detects Local Recurrence Occult on mpMRI in Prostate Cancer Patients After HIFU.
Burger IA, Müller J, Donati OF, Ferraro DA, Messerli M, Kranzbühler B, Ter Voert EEGW, Muehlematter UJ, Rupp NJ, Mortezavi A, Eberli D. Burger IA, et al. J Nucl Med. 2019 Aug;60(8):1118-1123. doi: 10.2967/jnumed.118.221564. Epub 2019 Jan 25. J Nucl Med. 2019. PMID: 30683764 Free article. Clinical Trial.
Role of intravoxel incoherent motion parameters in gastro-esophageal cancer: relationship with 18F-FDG-PET, CT perfusion and MR perfusion imaging parameters.
Schawkat K, Sah BR, Ter Voert EE, Delso G, Wurnig M, Becker AS, Leibl S, Schneider PM, Reiner CS, Huellner MW, Veit-Haibach P. Schawkat K, et al. Q J Nucl Med Mol Imaging. 2019 Sep 5. doi: 10.23736/S1824-4785.19.03153-4. Online ahead of print. Q J Nucl Med Mol Imaging. 2019. PMID: 31496202
How does PET/MR work? Basic physics for physicians.
Delso G, Ter Voert E, Veit-Haibach P. Delso G, et al. Abdom Imaging. 2015 Aug;40(6):1352-7. doi: 10.1007/s00261-015-0437-5. Abdom Imaging. 2015. PMID: 25906344 Review.
Pitfalls and Limitations in Simultaneous PET/MRI.
Delso G, ter Voert E, de Galiza Barbosa F, Veit-Haibach P. Delso G, et al. Semin Nucl Med. 2015 Nov;45(6):552-9. doi: 10.1053/j.semnuclmed.2015.04.002. Semin Nucl Med. 2015. PMID: 26522396 Review.
Multi-technique hybrid imaging in PET/CT and PET/MR: what does the future hold?
de Galiza Barbosa F, Delso G, Ter Voert EE, Huellner MW, Herrmann K, Veit-Haibach P. de Galiza Barbosa F, et al. Clin Radiol. 2016 Jul;71(7):660-72. doi: 10.1016/j.crad.2016.03.013. Epub 2016 Apr 21. Clin Radiol. 2016. PMID: 27108800 Review.
PET/MR Outperforms PET/CT in Suspected Occult Tumors.
Sekine T, Barbosa FG, Sah BR, Mader CE, Delso G, Burger IA, Stolzmann P, Ter Voert EE, von Schulthess GK, Veit-Haibach P, Huellner MW. Sekine T, et al. Clin Nucl Med. 2017 Feb;42(2):e88-e95. doi: 10.1097/RLU.0000000000001461. Clin Nucl Med. 2017. PMID: 27922861 Free article.
Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI.
Sah BR, Ghafoor S, Burger IA, Ter Voert EEGW, Sekine T, Delso G, Huellner M, Dedes KJ, Boss A, Veit-Haibach P. Sah BR, et al. J Nucl Med. 2018 Dec;59(12):1817-1822. doi: 10.2967/jnumed.118.209007. Epub 2018 Jun 7. J Nucl Med. 2018. PMID: 29880506 Free article. Clinical Trial.
Value of PET/MRI for assessing tumor resectability in NSCLC-intra-individual comparison with PET/CT.
Messerli M, de Galiza Barbosa F, Marcon M, Muehlematter UJ, Stolzmann P, Warschkow R, Delso G, Ter Voert EE, Huellner MW, Frauenfelder T, Veit-Haibach P. Messerli M, et al. Br J Radiol. 2018 Oct 11;92(1093):20180379. doi: 10.1259/bjr.20180379. Online ahead of print. Br J Radiol. 2018. PMID: 30209954 Free PMC article.
Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous 18F-choline PET/MRI for prostate cancer.
Muehlematter UJ, Nagel HW, Becker A, Mueller J, Vokinger KN, de Galiza Barbosa F, Ter Voert EEGT, Veit-Haibach P, Burger IA. Muehlematter UJ, et al. EJNMMI Res. 2018 May 31;8(1):41. doi: 10.1186/s13550-018-0390-8. EJNMMI Res. 2018. PMID: 29855728 Free PMC article.
46 results
Jump to page